These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38486078)

  • 1. Enoxaparin thromboprophylaxis in hospitalized obese pediatric patients.
    Yim J; Jahan A; Braykov N; Murphy ND; Woods GM
    Pediatr Blood Cancer; 2024 Sep; 71(9):e30942. PubMed ID: 38486078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin treatment dosing for venous thromboembolism in pediatric patients with obesity.
    Yim J; Jahan A; Braykov N; Woods GM
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31033. PubMed ID: 38702920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study.
    Miranda S; Le Cam-Duchez V; Benichou J; Donnadieu N; Barbay V; Le Besnerais M; Delmas FX; Cuvelier A; Lévesque H; Benhamou Y; Armengol G
    Thromb Res; 2017 Jul; 155():1-5. PubMed ID: 28460259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin dosing after cesarean delivery in morbidly obese women.
    Overcash RT; Somers AT; LaCoursiere DY
    Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin.
    Richard AA; Kim S; Moffett BS; Bomgaars L; Mahoney D; Yee DL
    J Pediatr; 2013 Feb; 162(2):293-6. PubMed ID: 22959138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Enoxaparin in Obese Adolescents During Bariatric Surgery--a Pilot Study.
    Mushtaq A; Vaughns JD; Ziesenitz VC; Nadler EP; van den Anker JN
    Obes Surg; 2015 Oct; 25(10):1869-74. PubMed ID: 25716128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
    Martin AM; Polistena P; Mahmud A; Bettridge B; Morling A; Chuah H; Yong ASM; Leahy MF
    Thromb Res; 2021 Nov; 207():116-122. PubMed ID: 34619448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
    Yam L; Bahjri K; Geslani V; Cotton A; Hong L
    Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients.
    Kramme K; Sarraf P; Munene G
    J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients.
    Cronin BJ; Godat LN; Berndtson AE; Pham A; Kolan S; Box K; Lee JG; Costantini TW
    Burns; 2019 Jun; 45(4):818-824. PubMed ID: 30827851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-factor Xa activity of enoxaparin for thromboprophylaxis in nonsurgical patients is dependent on body mass].
    Jiménez D; Díaz G; Iglesias A; César J; García-Avello A; Martí D; Escobar C; Vidal R; Sueiro A
    Arch Bronconeumol; 2008 Dec; 44(12):660-3. PubMed ID: 19091234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients.
    Chanas T; Gibson G; Langenstroer E; Herrmann DJ; Carver TW; Alexander K; Chui SHJ; Rein L; Ha M; Maynard KM; Bamberg K; O'Keefe M; O'Brien M; Gonzalez MC; Hobbs B; Pajoumand M; Peppard WJ
    Pharmacotherapy; 2024 Mar; 44(3):258-267. PubMed ID: 38148134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.
    Schloemer NJ; Abu-Sultaneh S; Hanson SJ; Yan K; Hoffmann RG; Punzalan RC; Havens PL
    Pediatr Crit Care Med; 2014 Sep; 15(7):e294-9. PubMed ID: 24901803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics of Enoxaparin in Pediatric Patients.
    Moffett BS; Lee-Kim Y; Galati M; Mahoney D; Shah MD; Teruya J; Yee D
    Ann Pharmacother; 2018 Feb; 52(2):140-146. PubMed ID: 28962537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Evaluation of the Appropriateness of Initial Enoxaparin Dosing Among Pediatric Patients.
    Altuwayjiri A; AlDarwish A; Alshuraim R
    Cureus; 2023 Nov; 15(11):e48830. PubMed ID: 38106767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.
    Rondina MT; Wheeler M; Rodgers GM; Draper L; Pendleton RC
    Thromb Res; 2010 Mar; 125(3):220-3. PubMed ID: 19272635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Body Mass Index-Based Prophylactic Enoxaparin Dosing in Bariatric Surgery Patients.
    Chang CK; Higgins RM; Rein L; Peppard WJ; Herrmann DJ; Kindel T
    J Surg Res; 2023 Jul; 287():168-175. PubMed ID: 36933548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.